GFAP
Published research on GFAP.

In 2 cohorts of adults over 60, having both insomnia and anxiety was linked to double the odds of cognitive impairment and a 54% higher rate of new dementia. Either condition alone was not.
Read article →
A 2026 PROTECT study involving 174 older adults found that self-administered fingerprick p-tau217 correlated with episodic memory (r = 0.299, p < 0.001) and GFAP correlated with working memo…
Read article →
Lecanemab blood biomarkers may rebound much faster than amyloid PET after treatment stops: a 2026 PK/PD model estimated that half of the Aβ42/40 treatment effect is lost within 0.5 years, co…
Read article →